Pzena Investment Management LLC acquired a new position in shares of Humana Inc. (NYSE:HUM – Free Report) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 476 shares of the insurance provider’s stock, valued at approximately $231,000.
A number of other large investors also recently modified their holdings of HUM. Cibc World Market Inc. boosted its stake in shares of Humana by 4.0% during the 1st quarter. Cibc World Market Inc. now owns 5,709 shares of the insurance provider’s stock worth $2,484,000 after buying an additional 217 shares during the last quarter. Blair William & Co. IL boosted its stake in shares of Humana by 0.6% during the 1st quarter. Blair William & Co. IL now owns 5,660 shares of the insurance provider’s stock worth $2,463,000 after buying an additional 32 shares during the last quarter. Cetera Investment Advisers boosted its stake in shares of Humana by 0.5% during the 1st quarter. Cetera Investment Advisers now owns 4,906 shares of the insurance provider’s stock worth $2,135,000 after buying an additional 26 shares during the last quarter. Sequoia Financial Advisors LLC boosted its stake in shares of Humana by 19.0% during the 1st quarter. Sequoia Financial Advisors LLC now owns 615 shares of the insurance provider’s stock worth $268,000 after buying an additional 98 shares during the last quarter. Finally, Candriam Luxembourg S.C.A. raised its holdings in shares of Humana by 25.0% in the 1st quarter. Candriam Luxembourg S.C.A. now owns 29,809 shares of the insurance provider’s stock valued at $12,971,000 after purchasing an additional 5,964 shares during the period. 91.86% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently issued reports on HUM shares. Morgan Stanley dropped their target price on shares of Humana from $637.00 to $624.00 and set an “overweight” rating on the stock in a report on Wednesday, August 30th. Barclays dropped their target price on shares of Humana from $620.00 to $585.00 in a report on Monday, June 19th. Truist Financial upped their target price on shares of Humana from $530.00 to $550.00 and gave the company a “hold” rating in a report on Thursday, August 3rd. TD Cowen dropped their target price on shares of Humana from $616.00 to $613.00 and set an “outperform” rating on the stock in a report on Tuesday, August 15th. Finally, Deutsche Bank Aktiengesellschaft upped their target price on shares of Humana from $468.00 to $628.00 and gave the company a “buy” rating in a report on Monday, August 7th. Four research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $592.30.
Humana Stock Down 0.9 %
NYSE HUM opened at $467.73 on Friday. The company has a current ratio of 1.37, a quick ratio of 1.37 and a debt-to-equity ratio of 0.58. Humana Inc. has a 1-year low of $423.29 and a 1-year high of $571.30. The company has a 50 day moving average of $465.41 and a 200-day moving average of $488.01. The company has a market cap of $57.96 billion, a price-to-earnings ratio of 17.45, a PEG ratio of 1.22 and a beta of 0.66.
Humana (NYSE:HUM – Get Free Report) last released its quarterly earnings results on Wednesday, August 2nd. The insurance provider reported $8.94 earnings per share for the quarter, beating analysts’ consensus estimates of $8.88 by $0.06. Humana had a net margin of 3.42% and a return on equity of 20.70%. The company had revenue of $26.75 billion during the quarter, compared to the consensus estimate of $25.83 billion. During the same period in the previous year, the business earned $8.67 earnings per share. The firm’s quarterly revenue was up 13.0% on a year-over-year basis. On average, equities research analysts expect that Humana Inc. will post 28.25 earnings per share for the current fiscal year.
Humana Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Friday, September 29th will be paid a $0.885 dividend. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $3.54 dividend on an annualized basis and a yield of 0.76%. Humana’s dividend payout ratio (DPR) is 13.21%.
Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
- Five stocks we like better than Humana
- How to Invest in Cannabis, Step by Step
- MarketBeat Week in Review – 9/4 – 9/8
- How to Invest in Pharmaceutical Companies
- The Best 5 Small Cap AI Companies to Buy Now
- Canada Bond Market Holiday: How to Invest and Trade
- Miso Robotics Stock: Is an IPO Coming Soon?
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.